Chromos and Genitope Corporation sign cell line engineering contract
16-Jan-2007
Under the agreement, Chromos will engineer cell lines for the expression of a monoclonal antibody for Genitope using the ACE System. The financial details of the agreement were not disclosed.
Other news from the department business & finance
Get the life science industry in your inbox
From now on, don't miss a thing: Our newsletter for biotechnology, pharma and life sciences brings you up to date every Tuesday and Thursday. The latest industry news, product highlights and innovations - compact and easy to understand in your inbox. Researched by us so you don't have to.